After the Drugs Controller General of India (DCGI) granted emergency use authorisation to the Defence Research and Development Organisation’s 2-DG drug for treatment of Covid-19 one week ago, 10,000 doses of the drug are expected to be released by Saturday.
Production of the 2-deoxy-D-glucose (2-DG) drug on a large-scale will start soon in Hyderabad and at other centres too. The drug has been developed by DRDO’s Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Hyderabad-based Dr Reddy’s Laboratories.
In recent years, India has made significant strides in the fight against cancer, with an…
As we age, our cognitive abilities naturally decline, but diet has emerged as a key…
In a significant move toward revolutionizing patient care, a panel discussion on Artificial Intelligence (AI)-based…
Breast cancer remains one of the leading causes of cancer-related deaths among women worldwide. Early…
Airport Proximity: Can living near an airport increase your risk of a heart attack? A…
Antimicrobial resistance (AMR), the ability of bacteria, fungi, and parasites to resist the effects of…